IBIO
IBIO
NASDAQ · Biotechnology

Ibio Inc

$1.26
+0.00 (+0.00%)
As of Sep 22, 4:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
59.3K
Net Income
-18,822,254
Gross Margin
38.4%
Profit Margin
-33,044.0%
Rev Growth
D/E Ratio
0.91
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.4% 38.4% 65.3% 65.3%
Operating Margin -35,141.0% -4,185.5% -16.4% -13.7%
Profit Margin -33,044.0% -4,364.5% -16.3% -13.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 59.3K 3.88M 19.24M 18.65M
Gross Profit 22.8K 1.49M 12.56M 12.17M
Operating Income -20,832,287 -162,546,892 -3,161,331 -2,555,901
Net Income -18,822,254 -160,579,998 -3,136,016 -2,526,921
Gross Margin 38.4% 38.4% 65.3% 65.3%
Operating Margin -35,141.0% -4,185.5% -16.4% -13.7%
Profit Margin -33,044.0% -4,364.5% -16.3% -13.6%
Rev Growth -40.3% -5.9% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 18.21M 18.98M 23.44M 21.95M
Total Equity 20.03M 20.88M 30.82M 33.89M
D/E Ratio 0.91 0.91 0.76 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -19,664,068 -164,610,909 -4,591,050 -4,236,243
Free Cash Flow -2,958,449 -2,128,422